Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Depreciation and Depletion (2016 - 2020)

Macrogenics (MGNX) has disclosed Depreciation and Depletion for 7 consecutive years, with $2.9 million as the latest value for Q4 2020.

  • On a quarterly basis, Depreciation and Depletion fell 4.21% to $2.9 million in Q4 2020 year-over-year; TTM through Dec 2020 was $12.0 million, a 28.33% increase, with the full-year FY2025 number at $7.2 million, down 4.0% from a year prior.
  • Depreciation and Depletion was $2.9 million for Q4 2020 at Macrogenics, down from $3.0 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $3.1 million in Q4 2019 to a low of $1.2 million in Q4 2016.
  • A 3-year average of $2.4 million and a median of $2.5 million in 2016 define the central range for Depreciation and Depletion.
  • Biggest YoY gain for Depreciation and Depletion was 324.74% in 2016; the steepest drop was 23.74% in 2016.
  • Macrogenics' Depreciation and Depletion stood at $1.2 million in 2016, then surged by 162.61% to $3.1 million in 2019, then fell by 4.21% to $2.9 million in 2020.
  • Per Business Quant, the three most recent readings for MGNX's Depreciation and Depletion are $2.9 million (Q4 2020), $3.0 million (Q3 2020), and $3.1 million (Q4 2019).